Colin Bond

Relypsa, Inc. operates as a bio-pharmaceutical company, which engages in the development and commercialization of late-stage medicines in the iron deficiency, nephrology, and cardio-renal therapeutic areas. It offers Veltassa, a potassium binder approved for the treatment of hyperkalemia. The company was founded by Jerry M. Buysse, Gerrit Klaerner, Michael Burdick, Jay P. Shepard, Detlef F. Albrecht, George Tyson, Sandra I. Coufal and Vic Ciaravino on October 29, 2007 and is headquartered in Redwood City, CA.

BioPharma Credit PLC operates as a closed-ended investment trust. The firm' objective is to generate predictable income for shareholders over the long term. It offers a diversified portfolio of loans and other instruments backed by royalties or other cash flows derived from sales of approved life sciences products. The company was founded on October 24, 2016 and is headquartered in Exeter, the United Kingdom.

Vifor Pharma Management AG develops and manufactures pharmaceuticals products for the treatment of iron deficiency. It also offers a diversified portfolio of prescription medicines as well as over-the-counter products. The company operates in the following key business areas: iron deficiency with and without anemia, kidney disease, infectious diseases/OTX products and consumer healthcare, with a focus on non-prescription products. Vifor Pharma Management was founded by Caspar Friedrich Hausmann in 1872 and is headquartered in Glattbrugg, Switzerland.

Part of Procter & Gamble Co., Procter & Gamble AG engages in marketing of consumer goods. The Swiss company was founded by Ofir Bar Levav.

Part of Arthur Andersen LLP, Arthur Andersen AG is a private company based in Geneva, Switzerland.

Vifor Pharma AG is a pharmaceutical company, which engages in the research, development, production, and marketing of therapeutic products. It operates through the following geographical segments: Switzerland, Europe, USA, Rest of World, and Group. The firm offers products for iron deficiency, nephrology, and cardio-renal therapies. It specializes in strategic global partnering, in-licensing and developing, manufacturing and marketing pharmaceutical products for precision patient care. The company was founded in 1927 and is headquartered in St. Gallen, Switzerland.

Part of Hindalco Industries Ltd., Novelis Europe Holdings Ltd. operates as a holding British company. The private company is based in Warrington, UK.

Vifor Fresenius Medical Care Renal Pharma Ltd. engages in the research in as well as development, marketing, and distribution of pharmaceutical products used in the field of nephrology for the treatment of patients suffering from chronic kidney disease. It offers products specialized in anemia, mineral, bone, and cardio-renal management. The company was founded on November 26, 2010 and is headquartered in St. Gallen, Switzerland.

The Institute of Chartered Accountants in England & Wales ensures that its members, students, and affiliates maintain the highest standards of professional competency and conduct to protect the public interest. The non-profit company is based in London, UK, and has subsidiaries in the United Kingdom. With over 150,000 members, the institute provides technical information, helplines, and communities to its members.

Jet Aviation AG engages in the provision of aviation and aerospace maintenance services. It offers private and business aviation support services, aircraft charter, aircraft completions or refurbishment, aircraft engineering services, fixed base operations, flight support, aircraft and maintenance management services. The company was founded by Carl W. Hirschmann in 1967 and is headquartered in Basel, Switzerland.

Founded in 1873, Siegfried AG is a chemical product manufacturing company. The private company is based in Zofingen, Switzerland and is a part of Siegfried Holding AG.

Part of Novartis AG, Sandoz AG is a Swiss company that develops generic medicines and biosimilars. The private company is based in Basel, Switzerland.